Vaccini: “Le conseguenze dei sieri Mrna sono lievi ad esito favorevole”

Lo scrive il Giornale Italiano di Cardiologia che pubblica un Expert Opinion della Società Italiana di Cardiologia, curato da una quindicina di esperti, tra i quali Gianfranco Sinagra (Centro Diagnosi e Trattamento Cardiomiopatie, Università Trieste)

epa09214211 A city health office worker prepares a vial of Pfizer COVID-19 vaccine during an inoculation drive in Marikina City, Metro Manila, Philippines, 20 May 2021. The Department of Health is working with local government units to suspend early announcements of vaccine brands available for scheduled vaccination dates and instead inform citizens right before inoculation in order to get consent. The move is aimed at encouraging equal confidence in all available vaccines and avoid overcrowding in inoculation centers caused by brand preference. EPA/ROLEX DELA PENA
epa09214211 A city health office worker prepares a vial of Pfizer COVID-19 vaccine during an inoculation drive in Marikina City, Metro Manila, Philippines, 20 May 2021. The Department of Health is working with local government units to suspend early announcements of vaccine brands available for scheduled vaccination dates and instead inform citizens right before inoculation in order to get consent. The move is aimed at encouraging equal confidence in all available vaccines and avoid overcrowding in inoculation centers caused by brand preference. EPA/ROLEX DELA PENA

Le Miocarditi e Pericarditi potenzialmente associate a vaccinazione mRNA contro il COVID-19, in particolare con vaccino ad mRNA Pfizer-BioNTech (BNT16

Articolo Premium

Questo articolo è riservato agli abbonati.

Accedi con username e password se hai già un abbonamento.

Scopri tutte le offerte di abbonamento sul nostro shop.Shop

Non hai un account? Registrati ora.

Argomenti:coronavirus

Riproduzione riservata © Il Piccolo